Welcome : Guest

PROTEOMICS - A GLOBAL STRATEGIC BUSINESS REPORT   

Research Abstract

This report analyzes the worldwide markets for Proteomics in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 82 companies including many key and niche players such as -

ActivX Biosciences, Inc.
Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc.
Bruker Daltonics, Inc.
Caprion Proteomics, Inc.

Click here to request a full list of companies covered in the report...

Code: MCP-1029
Price: $4950
Companies: 82
Pages: 234
Date: May 2014
Market Data Tables: 51
 



TABLE OF CONTENTS


  PROTEOMICS (Complete Report) Pages : 234   | $4950

   Study Reliability and Reporting Limitations.....I-1  
   Disclaimers.....I-2
Data Interpretation & Reporting Level.....I-2
  
   Product Definitions and Scope of Study.....I-3  
   Proteomics – The Current Spotlight.....II-11$100
   Proteomics: A Critical Drug Discovery Tool.....II-21$100
   Research to Dominate the Market in the Immediate Future.....II-3
Proteomics Technologies: Growing in Significance.....II-3
1$100
   New Developments in Proteomics Technologies.....II-41$100
   Market Drivers/Trends/Challenges.....II-5
Personalized Medicine Slowly Gaining Ground.....II-5
Table 1: Drug Ineffectiveness for Select Therapeutic Categories as a Percentage of Patient Population (includes corresponding Graph/Chart).....II-5
2$350
   Table 2: Global Population Statistics for the 65+ Age Group (2012) (includes corresponding Graph/Chart).....II-71$350
   Table 3: Percentage of Population Aged 65 and Above in Europe, US, and Japan (1960-2030) (includes corresponding Graph/Chart).....II-8

Table 4: Elderly Population (65+ Years) as a Percentage of the Total Population: 2025 (includes corresponding Graph/Chart).....II-8
Advancements in Proteomics Bring Biomarkers into Limelight.....II-8
1$350
   List of US-FDA Approved Biomarkers for Cancer.....II-91$100
   Oncology – A Key Focus Area for Proteomics.....II-10 1$100
   Table 5: World Cancer Incidence by Geographic Region and Gender (2012): Number of New Cancer Cases Reported (in Thousands) for Asia-Oceania, Europe, North America, Latin America & The Caribbean, and Africa (includes corresponding Graph/Chart).....II-111$350
   Table 6: New Cancer Cases in the World by Affected Site (2012) (in Thousands) (includes corresponding Graph/Chart).....II-121$350
   Table 7: Cancer Incidence in Developed Nations by Site: 2012 (includes corresponding Graph/Chart).....II-131$350
   Table 8: Global Incidence of Common Cancers in Men (2012): Number of New Cases Reported in Thousands for Lung & Bronchus, Prostate, Colorectal, and Liver Cancers (includes corresponding Graph/Chart).....II-14

Table 9: Global Incidence of Common Cancers in Women (2012): Number of New Cases Reported in Thousands for Breast, Colorectal, Lung & Bronchus, and Liver Cancers (includes corresponding Graph/Chart).....II-14
1$350
   Table 10: World Cancer Mortality by Geographic Region and Gender (2012): Number of Cancer- Related Deaths (in Thousands) for Asia-Oceania, Europe, North America, Latin America & The Caribbean, and Africa (includes corresponding Graph/Chart).....II-15
International Initiatives in the Proteomics Market.....II-15
1$350
   China All Set To Play a Major Role in the Proteomics Industry.....II-16
Global Proteomics Sample Preparation Market - On a Growth Curve.....II-16
1$100
   Challenges Facing Proteomics Sample Preparation Market.....II-17
Industrialization of Proteomics Research Propels Sample Preparation
  Technologies.....II-17
Factors Limiting Market Growth.....II-17
Impact of the Economic Recession on the Life Sciences Industry in Retrospect.....II-17
1$100
   Challenges Facing Proteomics Industry.....II-18
Protein Chemistry and its Complexities.....II-18
Quantitation.....II-18
Integration of Data & Equipment.....II-18
1$100
   Data Validation - A Burning Issue.....II-19
Standardization & Consistency - A Prime Concern.....II-19
Incomplete and Disorganized Data.....II-19
1$100
   A Highly Fragmented Market.....II-201$100
   Tool Providers: Leading the Proteomics Market.....II-21
Role of Contract Research Organizations - All Set to Increase in Proteomics.....II-21
1$100
   Proteins, Proteome and Proteomics!!! - What are they?.....II-22
Proteomics – An Introduction.....II-22
1$100
   Genesis of Proteomics.....II-231$100
   Components of Proteomics.....II-24
Expression Proteomics.....II-24
Functional Proteomics.....II-24
Cell-map Proteomics.....II-24
Structural Proteomics.....II-24
Technologies and Proteomics.....II-24
1$100
   Proteomics and Genomics.....II-25
Proteomics and Genomics: A Comparison.....II-25
Protein Production Pathway: From Gene Expression to Functional Protein with
  Controls.....II-25
1$100
   From Genomics to Proteomics.....II-26
Functional Genomics and Proteomics.....II-26
1$100
   Push from Genomic Information.....II-27
An Insight into Proteomics Data Type and their Characteristics / Features.....II-27
Standard Proteomics Approach.....II-27
1$100
   Sample Preparation - Step I.....II-28
Protein Separation - Step II.....II-28
Protein Visualization.....II-28
Protein Expression Analysis-Step III.....II-28
Image Analysis - Identify differentially expressed spots.....II-28
1$100
   Protein Identification - Step IV.....II-29
Data Storage and Processing - Step V.....II-29
1$100
   A Snapshot of Various Proteomics Tools.....II-30
An Insight into Various Proteomics Technologies and their Application Areas.....II-30
Protein Separation.....II-30
1$100
   2-Dimensional Gel Electrophoresis (2DGE).....II-31
Elements of 2-DE Proteomics.....II-31
Two -Dimensional Differential Gel Electrophoresis.....II-31
Combining 2D Gel Electrophoresis with Mass Spectrometry (MS).....II-31
1$100
   2D Capillary LC.....II-32
Analytical Strength of LC-MS and MS/MS in Shotgun Protein Sequencing.....II-32
Protein Characterization.....II-32
Analysis of Protein through Mass Spectrometry.....II-32
MS and Proteins.....II-32
1$100
   Comparison of MS Techniques.....II-33
Applications of MS.....II-33
1$100
   Problems Associated with MS.....II-34
Types of Analyzers or Filters.....II-34
MALDI-TOF MS.....II-34
MS/MS.....II-34
SELDI-TOF.....II-34
1$100
   Laser Capture Microdissection.....II-35
Tandem MS.....II-35
Y2H, Yeast 2-Hybrid System.....II-35
Sensitivity of Two-Hybrid Assays.....II-35
1$100
   Limitations of Y2H.....II-36
Protein Microarrays.....II-36
Market Influencers in Protein Microarrays Market.....II-36
Chip Technology.....II-36
1$100
   Microfluidic Applications.....II-37
Role of Bioinformatics in Proteomics.....II-37
Bioinformatics Applications and Tools in Proteomics.....II-37
MS Programs.....II-37
1$100
   2- DE gel Comparison.....II-38
2-DE Databases.....II-38
Databases of 2D-electrophoretic maps.....II-38
1$100
   Emerging Proteomics Technologies.....II-39
MudPIT.....II-39
ICAT.....II-39
ICAT strategy: A solution to quantitative proteome analysis.....II-39
Phage Display Technique.....II-39
1$100
   Advanced Proteomics Technologies: Structural Analysis Tools.....II-40
X-ray Crystallography.....II-40
Nuclear Magnetic Resonance (NMR).....II-40
In silico Modelling.....II-40
1$100
   Physicochemical Factors Constraining Metabolic Functions.....II-411$100
   End-Use Application Areas.....II-421$100
   Proteomics in Drug Discovery and Diagnostics.....II-43
Proteomics and Drug Discovery.....II-43
1$100
   Protein Microarrays: A New Tool for the Development of Pharmaceuticals.....II-44
Proteomic Approaches Gain Prominence in Cancer Drug Discovery.....II-44
1$100
   Proteomics Technologies Used in Cancer Drug Discovery and Development.....II-451$100
   Proteome Sciences Validates Novel Protein Biomarkers.....II-46
KineMed to Apply Its MS Proteomics Platform to Study Neurodegeneration.....II-46
Agilent and MRM Proteomics Introduce PeptiQuant Kits for High-Quality Plasma Proteomic
  Analysis.....II-46
Elsevier Launches ‘Translational Proteomics’ Open-Access Journal.....II-46
Applied Biomics Introduces Global Protein Post- Translational Modification Profiling
  Service.....II-46
1$100
   AB SCIEX Launches New Column Chips.....II-471$100
   Applied Biomics Introduces New Mass Spectrometry Service.....II-48
Norton Scientific Introduces Novel Specialist Applications Development Laboratory
  Service.....II-48
Gentel Biosciences Introduces APiX™ Disease Profiling Kit.....II-48
1$100
   Integromics Introduces OmicsHub Proteomics 2.0.....II-49
Bruker Introduces amaZon Speed Ion Trap Mass Spectrometers.....II-49
1$100
   Applied Biomics Introduces iTRAQ Service for Proteomics Research.....II-50
Norton Scientifc Introduces New Lab Support Service for Rapid RNA/DNA and Protein
  Measurement.....II-50
1$100
   Bruker Launches MALDI Biotarget™.....II-51
Thermo Fisher Launches UHLPC System.....II-51
1$100
   Kinexus Introduces Human Gene Online TranscriptoNET KnowledgeBase.....II-52
Bruker Launches PRIME Integrated Proteomics Solution.....II-52
1$100
   Applied Biosystems Launches LS*LIMS Laboratory Automation Technology for Proteomics and
  Genomics.....II-53
Kinexus Bioinformatics Introduces Online KiNET-AM Proteomics DataBase.....II-53
1$100
   Bruker Rolls Out CaptiveSpray Electrospray Ion Source for Proteomics
  Applications.....II-54
Thermo Fisher Launches New Capabilities for Performing Proteomics Workflows.....II-54
1$100
   National Cancer Institute Introduces Clinical Proteomic Tumor Analysis Consortium for
  Cancer Studies.....II-55
KinaSorb™ – New Kit for Kinase Enrichment.....II-55
1$100
   Retroscreen Virology Group Acquires Activiomics.....II-56
Thermo Fisher Scientific Acquires Life Technologies Corporation.....II-56
Fluidigm Corporation Buys DVS Sciences.....II-56
Geneva Bioinformatics Collaborates with University of Washington.....II-56
Applied Proteomics Partners with German Research Institute.....II-56
1$100
   Agilent Technologies Enters Agreement with SomaLogic.....II-57
Biognosys Partners with CellnTEC.....II-57
Proteome Sciences Enters Contract with Thermo Fisher Scientific.....II-57
Agilent Technologies Partners with Sera Prognostics.....II-57
Chicago Growth Partners Buys Caprion Proteomics from Thallion.....II-57
1$100
   GlaxoSmithKline Fully Acquires Cellzome.....II-58
Proteome Sciences Signs Agreement with CHDI Foundation.....II-58
Waters Corp. Inks Agreement with Nonlinear Dynamics.....II-58
BioFocus Enters into Alliance with Activiomics.....II-58
1$100
   Great Point Partners Divests Caprion Proteomics.....II-59
Glaxo Smith Kline Takes over Cellzome.....II-59
Emerald BioSystems Changes Name to Emerald Bio.....II-59
1$100
   Bruker Unveils Novel Nano-Advance UHPLC System.....II-60
Evotec Takes Over Kinaxo Biotechnologies.....II-60
Kinaxo Biotechnologies and AstraZeneca Sign Agreement.....II-60
Gentel Biosciences Takes over Eppendorf’s SilverQuant Trademark.....II-60
1$100
   Thermo Fisher Takes Over Fermentas International.....II-61
KINAXO to Collaborate with Takeda.....II-61
Dualsystems and Bulldog Bio Signs Exclusive Marketing Agreement.....II-61
1$100
   Novartis Enters into Agreement with SomaLogic.....II-62
Sage-N Inks Exclusive Pact with the U.S. Army.....II-62
Proteome Sciences Inks Agreement with Moffitt Cancer Center.....II-62
Gentel Biosciences Enters into Agreement with Oregon Health & Science
  University.....II-62
1$100
   Evotec OAI Forms Joint Venture with MeITec to Collaborate on Drug Discovery
  Services.....II-63
1$100
   ActivX Biosciences, Inc......II-64
Agilent Technologies, Inc......II-64
Bio-Rad Laboratories, Inc......II-64
1$100
   Bruker Daltonics, Inc......II-651$100
   Caprion Proteomics, Inc......II-66
Digilab Genomic Solutions, Inc......II-66
1$100
   GE Healthcare.....II-67
Geneva Bioinformatics S.A......II-67
1$100
   Hybrigenics SA.....II-68
EMD Millipore/Merck Millipore Corp......II-68
PerkinElmer, Inc......II-68
1$100
   Shimadzu Corporation.....II-69
Sigma-Aldrich Corporation.....II-69
1$100
   Thermo Fisher Scientific.....II-70
Waters Corp......II-70
1$100
   Xencor Inc......II-711$100
   Table 11: World Recent Past, Current & Future Analysis for Proteomics by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart).....II-721$350
   Table 12: World Historic Review for Proteomics by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart).....II-731$350
   Table 13: World 15-Year Perspective for Proteomics by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets for Years 2006, 2014 and 2020 (includes corresponding Graph/Chart).....II-741$350
   A. Market Analysis.....III-1
Current & Future Analysis.....III-1
Personalized Medicine – A Major Driver for the Proteomics Market.....III-1
1$75
   Table 14: US Market for Hospital Cancer Therapies by Treatment Type (2004 and 2010): Percentage Breakdown of Revenues for Surgery, Chemotherapy Drugs, Radiation Therapy, Biotechnology-Based Drugs, and Others (includes corresponding Graph/Chart).....III-2
Cancer Presumes Epidemic Proportion in the US.....III-2
1$200
   Table 15: New Cancer Cases by Gender and Affected Site in the US (2013).....III-31$200
   Proteomics to Provide POCT for Patients in Hospice Care.....III-4
Leading Market for Rapid and Automated Microbiological Tests.....III-4
1$75
   Demographic Changes Offer Growth Opportunities.....III-5
Table 16: North American Aging Population by Age Group: 1975-2050 (includes corresponding Graph/Chart).....III-5
1$200
   Proteomics Sample Preparation Market.....III-6
FDA’s Antidote.....III-6
New Product Launches.....III-6
6$395
   Strategic Corporate Developments.....III-126$395
   Key Players.....III-186$395
   B. Market Analytics.....III-24
Table 17: The US Recent Past, Current & Future Analysis for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart).....III-24
1$200
   Table 18: The US Historic Review for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart).....III-251$200
   A. Market Analysis.....III-26
Rising Incidence of Chronic Diseases Spurs Proteomics Demand.....III-26
1$75
   Table 19: New Cancer Cases in Canada by Gender and Affected Site (2012) (includes corresponding Graph/Chart).....III-271$200
   Table 20: New Cancer Cases in Canada by Province (2012) (includes corresponding Graph/Chart).....III-281$200
   Table 21: New Cancer Cases in Canada by Age Group and Gender (2012) (includes corresponding Graph/Chart).....III-291$200
   New Product Developments.....III-301$75
   Strategic Corporate Development.....III-31
Caprion proteomics, Inc. - A Key Player.....III-31
1$75
   B. Market Analytics.....III-32
Table 22: Canadian Recent Past, Current & Future Analysis for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart).....III-32
1$200
   Table 23: Canadian Historic Review for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart).....III-331$200
   A. Market Analysis.....III-34
Demographics Drive Market Growth.....III-34
Table 24: Percentage Breakdown of Japanese Population by Age Group (2012) (includes corresponding Graph/Chart).....III-34
1$200
   Table 25: Over 65 Years Population in Japan (1950-2010) (includes corresponding Graph/Chart).....III-35
Shimadzu Corp. – A Key Player.....III-35
1$200
   B. Market Analytics.....III-36
Table 26: Japanese Recent Past, Current & Future Analysis for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart).....III-36
1$200
   Table 27: Japanese Historic Review for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart).....III-371$200
   A. Market Analysis.....III-38
Debt Crisis in Europe Affects Healthcare Industry.....III-38
European Healthcare System: In a State of Transition?.....III-38
Cancer Trends.....III-38
1$75
   Table 28: Cancer Incidence in Europe by Site: 2012 (in Thousands) (includes corresponding Graph/Chart).....III-391$200
   Aging Population to Drive Demand for Proteomics.....III-40
Table 29: Population Breakup by Age Group for Select European Countries: 2012 (As a % of Total Population) (includes corresponding Graph/Chart).....III-40
1$200
   European Personalized Medicine Market to Exhibit Robust Growth.....III-41
Proteomics Market in Europe.....III-41
Table 30: European Proteomics Market (2013): Percentage Breakdown of Deployment of Proteomics Technologies in End-Use Segment - Research and Academic Institutions, Pharmaceutical Companies, and Clinical Laboratories (includes corresponding Graph/Chart).....III-41
Proteomics Research in Europe – An Overview.....III-41
1$200
   Protein Identification Market.....III-421$75
   Protein Separation Market.....III-43
Market Challenges.....III-43
Gaining Edge in the Proteomics Industry – Player Strategies.....III-43
1$75
   European 2DE Market – Benefiting from Recession.....III-44
New Product Developments.....III-44
1$75
   Strategic Corporate Developments.....III-452$150
   Select Key Players.....III-472$150
   B. Market Analytics.....III-49
Table 31: European Recent Past, Current & Future Analysis for Proteomics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart).....III-49
1$200
   Table 32: European Historic Review for Proteomics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart).....III-501$200
   Table 33: European 15-Year Perspective for Proteomics by Geographic Region - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2006, 2014 and 2020 (includes corresponding Graph/Chart).....III-511$200
   A. Market Analysis.....III-52
French Proteomics Player – Hybrigenics Sa.....III-52
1$75
   B. Market Analytics.....III-53
Table 34: French Recent Past, Current & Future Analysis for Proteomics Independently Analyzed with Annual Sales Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart).....III-53
1$200
   Table 35: French Historic Review for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart).....III-541$200
   Market Analysis.....III-55
Table 36: German Recent Past, Current & Future Analysis for Proteomics Independently Analyzed with Annual Sales Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart).....III-55
1$200
   Table 37: German Historic Review for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart).....III-561$200
   Market Analysis.....III-57
Table 38: Italian Recent Past, Current & Future Analysis for Proteomics Independently Analyzed with Annual Sales Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart).....III-57
1$200
   Table 39: Italian Historic Review for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart).....III-581$200
   A. Market Analysis.....III-59
Highlights.....III-59
Increased Support for Personalized Medicine to Drive Proteomics Demand.....III-59
Strategic Corporate Development.....III-59
1$75
   Key Player – Ge Healthcare.....III-601$75
   B. Market Analytics.....III-61
Table 40: The UK Recent Past, Current & Future Analysis for Proteomics Independently Analyzed with Annual Sales Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart).....III-61
1$200
   Table 41: The UK Historic Review for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart).....III-621$200
   A. Market Analysis.....III-63
Key Swiss Player - Geneva Bioinformatics S.A......III-63
B. Market Analytics.....III-63
Table 42: Rest of European Recent Past, Current & Future Analysis for Proteomics Independently Analyzed with Annual Sales Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart).....III-63
1$200
   Table 43: Rest of European Historic Review for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart).....III-641$200
   A. Market Analysis.....III-65
Healthcare Spending in Asia-Pacific: On the Rise.....III-65
China.....III-65
1$75
   Table 44: China - The Most Populous Country Worldwide (July 2013): Total Population (in Millions) by Age Group 0-14 Years, 15-44 Years, 45-64 Years, and 65+ Years for China Vis-a-Vis Other Countries (includes corresponding Graph/Chart).....III-661$200
   Table 45: China - The Most Populous Country Worldwide (July 2013): Percentage Population by Age Group 0-14 Years, 15-44 Years, 45-64 Years, and 65+ Years for China Vis-a-Vis Other Countries (includes corresponding Graph/Chart).....III-67
Government Support Drives Personalized Medicine Market in China.....III-67
1$200
   Australia.....III-68
India.....III-68
Indian Scientific Research towards Functional Genomics and Proteomics.....III-68
1$75
   B. Market Analytics.....III-69
Table 46: Asia-Pacific Recent Past, Current & Future Analysis for Proteomics Independently Analyzed with Annual Sales Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart).....III-69
1$200
   Table 47: Asia-Pacific Historic Review for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart).....III-701$200
   Market Analysis.....III-71
Table 48: Latin American Recent Past, Current & Future Analysis for Proteomics Independently Analyzed with Annual Sales Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart).....III-71
1$200
   Table 49: Latin American Historic Review for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart).....III-721$200
   Market Analysis.....III-73
Table 50: Rest of World Recent Past, Current & Future Analysis for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart).....III-73
1$200
   Table 51: Rest of World Historic Review for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart).....III-741$200
  
Total Companies Profiled: 82 (including Divisions/Subsidiaries - 85)

Region/Country Players

The United States 54 Canada 4 Japan 2 Europe 24 France 3 Germany 6 The United Kingdom 7 Spain 1 Rest of Europe 7 Asia-Pacific (Excluding Japan) 1
Click here to request a full table of contents and more details on this project.